Japan

Japan's leading drugmaker Astellas has announced that it is to divest three of its European production units to German drugmaker Temmler Group. Astellas has previously announced... 2006-12-22

Sales for Japan's leading drugmakers, rose by 6% to JPY2,845.8bn (US$24.5bn) in H106, in what BMI believes is an encouraging performance considering the 6.7% cut in reimbursement... 2006-12-01

Japan could become one of the most important generics markets in Asia as the government looks to encourage this low cost sector as a means of restricting drug expenditure. Foreign... 2006-11-30

The Gulf Co-operation Council (GCC) is expected to sign a Free Trade Agreement (FTA) with Japan in the first half of 2007, which could greatly help the development of the region's... 2006-11-23

Innovative Japanese drugmaker Eisai has received a positive opinion on its anti-epileptic Inovelon (rufinamide) from the European Committee for Medicinal Products (CHMP). The drug... 2006-11-23

UK drug major GlaxoSmithKline (GSK) has filed its salmeterol + fluticasone propionate combination drug for Chronic Obstructive Pulmonary Disorder (COPD) in Japan. The inhalable product... 2006-11-20

In a possible change to its core growth strategy, leading Japanese drugmaker Takeda could be poised to make another large acquisition. The company - which has estimated cash reserves... 2006-11-15

Japanese drugmaker Astellas is seeking a declaratory judgement to confirm that a co-marketing deal with Pfizer, regarding the latter's blockbuster cholesterol-lowering drug Lipitor... 2006-11-10

Leading Japanese drugmaker Takeda has announced another disappointment regarding its R&D pipeline. Following the discontinuation of development on diabetes compound TAK-654 in... 2006-11-03

Third-ranked Japanese drugmaker Astellas has once again changed its profit forecasts, revising earlier projections for the first half of the 2006-07 financial year upwards by 40%... 2006-10-27